Benzinga's Top Initiations
September 12, 2016 at 09:02 AM EDT
Rodman & Renshaw initiated coverage on Oasmia Pharmaceutical AB (NASDAQ: OASM) with a Buy rating. The price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.